Penn Medicine - Abramson Cancer Center The Children's Hospital of Philadelphia Penn Medicine - Center for Cellular Immunotherapies

CAR-T and the Rise of Cellicon Valley

banner image

CAR-T and The Rise of the Cellicon Valley

presented by
Penn's Abramson Cancer Center, Children's Hospital of Philadelphia and
Penn's Center for Cellular Immunotherapies

 

View/Download Syllabus
 

Thursday, May 9 and Friday, May 10, 2019

Overview

CAR T represents a turning point in the history of human medicine, a genuine revolution in our approach to disease within the field of cellular therapy and transplant. The recent approval of chimeric antigen receptor (CAR) T cells offers even patients with highly chemo-refractory hematologic malignancies additional treatment options. World experts in CAR T-cellular therapy and hematopoietic stem cell transplantation (HSCT) have been assembled to discuss the development and implementation of this therapy and to weigh in on current applications, best practices, novel strategies and future developments for CAR T cells.

Who Should Attend

These activities are intended for both adult and pediatric hematologist-oncologists, medical oncologists, hematologists, hematopathologists, immunologists, immunobiologists, transfusion medicine, researchers and other oncology healthcare professionals interested in the latest advances in the use of CAR T-cell therapy. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in the treatment of adult and pediatric patients with cellular therapies are also invited to attend. Patients and their caregivers, family members, advocates and the general public who may benefit from understanding current cellular therapy approaches are also invited.

Learning Objectives

Upon completion of this course, participants should be able to:

  • Identify current application of CAR T-cell therapy including: accurate patient selection, manufacture and treatment administration
  • Implement guidelines for patient management of toxicities of CAR T-cell therapies including cytokine-release syndrome
  • List factors in overcoming resistance with novel CAR strategies
  • Describe gene delivery and editing for CARs
  • Identify the latest targets and technologies for CARs
  • Identify the current status of globalization of CAR T-cell therapies and identify principles in ethics of patient access
  • Describe current approaches in treatment and supportive care for hematopoietic stem cell transplantation (HSCT) in pediatric patients with nonmalignant conditions
  • Identify the latest evidence based standards in nursing care resulting from the recent advances in cell therapy  and transplant

Tour Center for Advanced Cellular Therapeutics

* Tour registration is closed, capacity has been reached. Tour participants notified via email with slot assignment.*
Thursday, May 9, 2019
2:00 pm to 4:00 pm

Keynote Address and Cocktail Reception

Thursday, May 9, 2019
3:30 pm to 6:45 pm
Irvine Auditorium and Perelman Quadrangle
3401/3417 Spruce Street
Philadelphia, PA 19104

Dinner

Thursday, May 9, 2019
7:00 pm - 9:00 pm
The University of Pennsylvania Museum of Archaeology and Anthropology
3260 South Street
Philadelphia, PA 19104

Educational Conference

Friday, May 10, 2019
7:30 am to 5:00 pm
Irvine Auditorium and Perelman Quadrangle
3401/3417 Spruce Street
Philadelphia, PA 19104

For additional information please contact Barbara Lopez at lopezb@pennmedicine.upenn.edu.

Online registration for this event is now closed.
Walk-ins are welcomed.